Topic: Health

Scientists at ETH Zurich discovered a new trigger of Alzheimer's disease and developed a drug that stops it. The treatment slowed down nerve cell loss, helped mice live longer, and targeted a biological process not addressed by existing drugs.

In a breakthrough in Alzheimer's research, scientists at ETH Zurich have found a new way to slow down the progression of the disease. They developed an experimental compound called Compound 10 that reduced nerve cell loss, helped mice live longer, and targeted a biological process not addressed by existing drugs.

The researchers, led by Ursula Quitterer, Professor of Molecular Pharmacology at ETH Zurich, have been working on this project for nearly two decades. Their journey began with the study of a protein called GRK2, which plays an important role throughout the body. They found that inactive GRK2 molecules accumulate in large amounts in the brains of people with dementia and mice with Alzheimer's-like symptoms.

Further experiments revealed that these inactive GRK2 molecules clump together inside nerve cells, attach to mitochondria, and interfere with their function. This leads to a situation of stress inside the cells, which accelerates the disease process.

To interrupt this cycle, the researchers designed and tested several experimental compounds in cell cultures and mice. Among them, Compound 10 delivered the strongest results. It prevented GRK2 molecules from forming harmful aggregates, allowing mitochondria to function more effectively.

The benefits of Compound 10 extended beyond the brain. In mice, it also appeared to improve heart function and influence aging-related changes. The researchers observed that treated animals developed fewer gray hairs as they grew older.

Why It Matters

This breakthrough could lead to new treatments for Alzheimer's disease, which affects millions of people worldwide. As India's population ages, understanding the causes and potential treatments of this disease is crucial.

Key Facts

• Scientists at ETH Zurich developed an experimental compound called Compound 10 that slows down the progression of Alzheimer's disease.
• Compound 10 targets a biological process not addressed by existing drugs.
• The treatment reduced nerve cell loss, helped mice live longer, and improved heart function in mice.

Key Terms

GRK2

A protein that plays an important role throughout the body, including the brain.

Implications

This breakthrough could lead to new treatments for Alzheimer's disease, which affects millions of people worldwide. As India's population ages, understanding the causes and potential treatments of this disease is crucial.